share_log

诚达药业:关于达格列净原料药通过CDE审批的公告

Chengda Pharmaceuticals: Announcement regarding the approval of the active pharmaceutical ingredient Dapagliflozin by the CDE.

SZSI ·  Nov 14
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more